Robin Nance, UW Biostat grad (MS ’04) and current doctoral student in epidemiology, is among the lead authors of this new study. She's credited with helping to develop the statistical models "that formed the backbone of the paper.”
A new study published earlier this month in PLOS Pathogens has pinpointed genetic variants that markedly increase HIV infection risk among people exposed to the virus. Mary Emond, co-senior author and primary analyst of the study and research associate professor of biostatistics in the UW Department of Biostatistics is quoted.
How are UW faculty in biostatistics working to prevent the spread of HIV? This article highlights Thomas Fleming's role in two new large-scale trials of a long-acting injectable drug for HIV prevention, and illuminates the integral role the biostatistician plays on a research team. Other UW faculty members in biostatistics actively involved in leading research for preventing the spread of HIV are also highlighted including: James Hughes, Peter Gilbert, Barbra Richardson and Ying Chen.
Several faculty members of the School's Department of Biostatistics are actively involved in leading the research for preventing the spread of HIV, including James Hughes, Peter Gilbert and Barbra Richardson.
Dr. Thomas Fleming, a UW faculty member in biostatistics, is involved in two large clinical trials engaging more than 6,000 people at high risk for acquiring HIV infection. The trials are aimed at determining whether an injectable medication, given only about every eight weeks, has effectiveness in reducing the risk of HIV infection that is similar or superior to that of a daily antiretroviral pill known as Truvada.